Literature DB >> 12663626

A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine.

Allen B King, Dana Armstrong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12663626     DOI： 10.2337/diacare.26.4.1322

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing.

Authors:  Allen B King; Dana U Armstrong
Journal:  J Diabetes Sci Technol       Date:  2007-01

Review 2.  Insulin glargine: an updated review of its use in the management of diabetes mellitus.

Authors:  Christopher J Dunn; Greg L Plosker; Gillian M Keating; Kate McKeage; Lesley J Scott
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin.

Authors:  R Schiaffini; P I Patera; C Bizzarri; P Ciampalini; M Cappa
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

Review 4.  A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

Authors:  Allen B King; Akio Kuroda; Munehide Matsuhisa; Todd Hobbs
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.